11–20 of 25 posts
Based on unpublished data, and the article neither names the drug nor says anything about the kind of study this claim is based on. Not something to get excited about.
I kinda understand wanting to have people not rush to testing the drug, though if both are administered by infusion the risk of self-medication is reduced. Better wait for the article.
Based on unpublished data, and the article neither names the drug nor says anything about the kind of study this claim is based on. Not something to get excited about.
I kinda understand wanting to have people not rush to testing the drug, though if both are administered by infusion the risk of self-medication is reduced. Better wait for the article.
How quickly should testing of a drug expand? That depends on a balance of risks. The faster you go, the more danger there is of the drug having bad side-effects while you're figuring out how safe and effective it is. The slower you go, the more you delay the possible benefits if the drug ends up working. Right now the potential benefits of such a drug are enormous -- or, put another way, each day of delay is a minor catastrophe. That should tilt the scales a lot.
Sometimes the careful, cautious thing to do is to go fast!
https://translate.google.com/translate?hl=en&sl=auto&tl=en&u...
Apparently one drug is an intravenous chemo drug administered only one time.
reads like a common scam
https://www.evaluate.com/vantage/articles/news/corporate-str...
Based on unpublished data, and the article neither names the drug nor says anything about the kind of study this claim is based on. Not something to get excited about.
camostat mesilate
Based on unpublished data, and the article neither names the drug nor says anything about the kind of study this claim is based on. Not something to get excited about.